← All stocks

Incyte

INCY Scheduled selling only
CIK 0000879169 #251 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$55.54M
$41.42M on a plan · $14.12M straight out of an exercise
Sold at will
$0.00
0 of 47 sales
Net
−$55.54M
$0.00 against sales at will

By person

27 insiders · 50 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Hoppenot Herve
Director
$19.77M (1) scheduled
−$19.77M
326,803
0.1612%
$41.03M
−34.2%
CAGNONI PABLO J
President, Global Head of R&D
$11.30M (7) scheduled
−$11.30M
183,200
0.0904%
$23.00M
−18.5%
Stein Steven H
CMO & Head of Late-Stage Dev.
$7.86M (6) scheduled
−$7.86M
30,916
0.0153%
$3.88M
−67.5%
Mayes Patrick A
EVP & Chief Scientific Officer
$6.56M (15) scheduled
−$6.56M
61,441
0.0303%
$7.71M
−8.8%
Morrissey Michael James
EVP, Head of Tech. Operations
$5.68M (3) scheduled
−$5.68M
34,065
0.0168%
$4.28M
−52.9%
Clancy Paul J
Director
$1.42M (1) scheduled
−$1.42M
25,635
0.0126%
$3.22M
+34.8%
Issa Mohamed Khairie
EVP, Head of U.S. Commercial
$1.31M (2) scheduled
−$1.31M
71,797
0.0354%
$9.01M
Tray Thomas
Principal Accounting Officer
$878.95K (6) scheduled
−$878.95K
21,699
0.0107%
$2.72M
−13.7%
Denton Sheila A.
EVP & General Counsel
$465.18K (5) scheduled
−$465.18K
26,569
0.0131%
$3.34M
−19.8%
Heeson Lee
EVP, Head of Incyte Intl
$289.02K (1) scheduled
−$289.02K
38,041
0.0188%
$4.78M
BAKER BROS. ADVISORS LP entity
Director
28,205,760
13.92%
$3.54B
+0.2%
Meury William
Chief Executive Officer
183,129
0.0903%
$22.99M
Stamoulis Christiana
EVP & Chief Financial Officer
125,759
0.0620%
$15.79M
+32.1%
SWAIN PAULA J
EVP, Human Resources
106,482
0.0525%
$13.37M
+23.7%
Iyengar Vijay K
EVP, GMAPPS
40,540
0.0200%
$5.09M
+9.5%
Flannelly Barry P
EVP & General Manager US
35,149
0.0173%
$4.41M
−39.4%
Upadhyay Suketu
EVP & Chief Financial Officer
26,343
0.0130%
$3.31M
BIENAIME JEAN JACQUES
Director
24,424
0.0120%
$3.07M
+33.3%
HARRIGAN EDMUND
Director
23,019
0.0114%
$2.89M
+40.8%
FOUSE JACQUALYN A
Director
20,968
0.0103%
$2.63M
+24.8%
Hoffman Richard A.
EVP & General Counsel
16,861
0.0083%
$2.12M
Gardner David H
EVP, Chief Strategy Officer
16,824
0.0083%
$2.11M
High Katherine A
Director
14,983
0.0074%
$1.88M
+38.4%
Trotta Matteo
EVP, GM, Dermatology US
14,882
0.0073%
$1.87M
+36.8%
BRAWLEY OTIS W
Director
12,894
0.0064%
$1.62M
+47.6%
Basi Ramitpal K
EVP, Human Resources
10,993
0.0054%
$1.38M
Schaffert Susanne
Director
7,389
0.0036%
$927.76K
+29.2%
Insider
Date
Role
Action
Shares
Price
Amount
CAGNONI PABLO J
19 Aug 2026
President, Global Head of R&D
Sold on a plan
10,801
$125.56
$1.36M
CAGNONI PABLO J
12 Aug 2026
President, Global Head of R&D
Sold on a plan
10,803
$120.04
$1.30M
Mayes Patrick A
5 Aug 2026
EVP & Chief Scientific Officer
Sold after exercise
2,207
$123.99
$273.65K
CAGNONI PABLO J
5 Aug 2026
President, Global Head of R&D
Sold on a plan
10,640
$122.69
$1.31M
Mayes Patrick A
3 Aug 2026
EVP & Chief Scientific Officer
Sold after exercise
6,055
$120.43
$729.20K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
2,293
$119.41
$273.81K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
326
$121.69
$39.67K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
85
$122.19
$10.39K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
1,642
$119.38
$196.02K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
1,643
$119.51
$196.35K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
2,864
$119.40
$341.96K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
4,695
$119.39
$560.54K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
6,171
$119.43
$737.00K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
2,187
$119.47
$261.28K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
5,332
$119.42
$636.75K
Mayes Patrick A
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
14,661
$119.46
$1.75M
CAGNONI PABLO J
31 Jul 2026
President, Global Head of R&D
Sold on a plan
15,888
$119.70
$1.90M
Issa Mohamed Khairie
16 Jul 2026
EVP, Head of U.S. Commercial
Sold on a plan
1,093
$115.01
$125.71K
Stein Steven H
16 Jul 2026
CMO & Head of Late-Stage Dev.
Sold on a plan
1,877
$114.73
$215.35K
Stein Steven H
15 Jul 2026
CMO & Head of Late-Stage Dev.
Sold on a plan
28,237
$113.05
$3.19M
Tray Thomas
4 Jun 2026
Principal Accounting Officer
Sold after exercise
2,639
$100.00
$263.90K
BIENAIME JEAN JACQUES
26 May 2026
Director
Exercised, kept
15,000
$84.53
$1.27M
Tray Thomas
26 May 2026
Principal Accounting Officer
Sold on a plan
2,051
$97.35
$199.66K
Clancy Paul J
19 May 2026
Director
Sold after exercise
15,000
$94.93
$1.42M
BAKER BROS. ADVISORS LP
8 May 2026
Director
Exercised, kept indirect
15,000
$84.53
$1.27M
BAKER BROS. ADVISORS LP
8 May 2026
Director
Exercised, kept indirect
15,000
$84.53
$1.27M
CAGNONI PABLO J
17 Apr 2026
President, Global Head of R&D
Sold after exercise
18,667
$96.50
$1.80M
CAGNONI PABLO J
17 Mar 2026
President, R&D
Sold after exercise
18,667
$94.24
$1.76M
CAGNONI PABLO J
19 Feb 2026
President, R&D
Sold after exercise
18,668
$100.91
$1.88M
Issa Mohamed Khairie
7 Jan 2026
EVP, Head of US Oncology
Sold on a plan
10,856
$109.07
$1.18M
Stein Steven H
5 Jan 2026
EVP & Chief Medical Officer
Sold on a plan
15,634
$101.70
$1.59M
Tray Thomas
19 Dec 2025
Principal Accounting Officer
Sold after exercise
2,774
$100.00
$277.40K
Tray Thomas
18 Dec 2025
Principal Accounting Officer
Sold on a plan
600
$98.25
$58.95K
Morrissey Michael James
17 Dec 2025
EVP, Head of Tech. Operations
Sold on a plan
4,323
$97.26
$420.45K
Morrissey Michael James
16 Dec 2025
EVP, Head of Tech. Operations
Sold on a plan
53,175
$97.29
$5.17M
Morrissey Michael James
16 Dec 2025
EVP, Head of Tech. Operations
Sold on a plan
833
$97.42
$81.15K
Mayes Patrick A
11 Dec 2025
EVP & Chief Scientific Officer
Sold on a plan
255
$94.94
$24.21K
Mayes Patrick A
10 Dec 2025
EVP & Chief Scientific Officer
Sold on a plan
5,553
$95.58
$530.76K
Stein Steven H
2 Dec 2025
EVP & Chief Medical Officer
Sold on a plan
20,105
$102.51
$2.06M
Stein Steven H
1 Dec 2025
EVP & Chief Medical Officer
Sold on a plan
2,559
$102.96
$263.47K
Tray Thomas
24 Nov 2025
Principal Accounting Officer
Sold on a plan
600
$103.00
$61.80K
Tray Thomas
21 Nov 2025
Principal Accounting Officer
Sold on a plan
169
$102.00
$17.24K
Denton Sheila A.
17 Nov 2025
EVP & General Counsel
Sold after exercise
278
$104.36
$29.01K
Hoppenot Herve
10 Nov 2025
Director
Sold on a plan
187,500
$105.46
$19.77M
Stein Steven H
5 Nov 2025
EVP & Chief Medical Officer
Sold after exercise
5,233
$102.20
$534.81K
Denton Sheila A.
4 Nov 2025
EVP & General Counsel
Sold after exercise
598
$101.36
$60.61K
Heeson Lee
3 Nov 2025
EVP, Head of Incyte Intl
Sold on a plan
3,074
$94.02
$289.02K
Denton Sheila A.
15 Oct 2025
EVP & General Counsel
Sold after exercise
277
$85.13
$23.58K
Denton Sheila A.
3 Oct 2025
EVP & General Counsel
Sold on a plan
3,501
$85.54
$299.48K
Denton Sheila A.
2 Oct 2025
EVP & General Counsel
Sold after exercise
599
$87.65
$52.50K

What was left out

Form 4 filings counted 93
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 23
Sales straight out of an exercise 24
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 682,583
History held since 26 Sep 2016